Saturday, February, 23, 2019 01:57:28

Category: Biotechnology

Diploid & Genomenon team up to advance rare disease diagnostics

In a major effort to develop genome interpretation for the rare disease diagnostics, Genomenon, a top genomic research company, and Diploid, a prominent AI-based software company for rare disease diagnostics, have reportedly inked a partnership deal. Sources with the knowledge of the matter stated that …

MeiraGTx and Janssen to develop gene therapies for IRD treatments

The latest transaction is the second significant collaboration by the two companies MeiraGTx Holdings Plc, a clinical-stage gene therapy company, has reportedly inked a strategic collaboration agreement with Janssen Pharmaceuticals, Inc., in a bid to develop and commercialize gene therapies for the IRD (inherited retinal …

Vedanta Biosciences raises $27M for microbiome-derived products

 The $27 million were raised in a Series-C financing with investors like Bristol-Myers Squibb and Bill & Melinda Gates Foundation participating in the round.  The money would be utilized to advance the company’s microbiome-derived product candidates. Vedanta Biosciences, Inc. (Vedanta), a renowned PureTech Health affiliate, …

Voluntis & AbbVie team up to develop companion digital therapeutics

Voluntis, a company specializing in digital therapeutics, has reportedly announced that it has formed a collaboration with research-based global biopharmaceutical company AbbVie, in order to improve patient care coordination in immunology through innovative digital therapeutic software. As per trusted sources, the companies will collectively leverage …